File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Retrospective analysis of survival in 81 women with early epithelial ovarian carcinoma who had not undergone systematic lymphadenectomy

TitleRetrospective analysis of survival in 81 women with early epithelial ovarian carcinoma who had not undergone systematic lymphadenectomy
Authors
KeywordsLymph Node Excision
Ovarian Neoplasms
Survival Rate
Issue Date2008
Publisher上海市腫瘤研究所. The Journal's web site is located at http://zzll.chinajournal.net.cn/
Citation
Tumor, 2008, v. 28 n. 12, p. 1059-1063 How to Cite?
AbstractObjective: This study aims to investigate whether postoperative adjuvant chemotherapy had any influence on the survival rate of those women with early ovarian carcinoma who did not receive pelvic lymphadenectomy and secondary surgery. Methods: This work conducted a retrospective review on all apparently stage I epithelial ovarian carcinoma patients who had not undergone lymphadenectomy in Queen Mary hospital, Hong Kong, within a ten-year period, from January of 1992 to December of 2002. Results: This work collected the clinical data from 81 patients. Twenty-three patients were apparently at stage IA, 1 patient at stage IB, and 57 patients at stage IC. The mean age was 47 years old (21-81 years) and the median follow-up period was 110 months (50-179 months). Totally 64 (79.0%) patients received adjuvant chemotherapy. The 5-year overall survival rate was 91.4% and 4-year progression free survival rate was 85.2%, which were similar to the survival rates described in the literature for patients who had undergone systematic lymphadenectomy. Conclusion: With provision of appropriate adjuvant chemotherapy, women with apparent stage I disease who have not undergone pelvic lymphadenectomy may achieve similar long-term survival rate to those who have undergone systematic lymphadectomy.
Persistent Identifierhttp://hdl.handle.net/10722/173359
ISSN
2015 SCImago Journal Rankings: 0.113
References

 

DC FieldValueLanguage
dc.contributor.authorChen, JHen_US
dc.contributor.authorChan, KKLen_US
dc.contributor.authorTam, KFen_US
dc.contributor.authorNgan, HYSen_US
dc.date.accessioned2012-10-30T06:29:37Z-
dc.date.available2012-10-30T06:29:37Z-
dc.date.issued2008en_US
dc.identifier.citationTumor, 2008, v. 28 n. 12, p. 1059-1063en_US
dc.identifier.issn1000-7431en_US
dc.identifier.urihttp://hdl.handle.net/10722/173359-
dc.description.abstractObjective: This study aims to investigate whether postoperative adjuvant chemotherapy had any influence on the survival rate of those women with early ovarian carcinoma who did not receive pelvic lymphadenectomy and secondary surgery. Methods: This work conducted a retrospective review on all apparently stage I epithelial ovarian carcinoma patients who had not undergone lymphadenectomy in Queen Mary hospital, Hong Kong, within a ten-year period, from January of 1992 to December of 2002. Results: This work collected the clinical data from 81 patients. Twenty-three patients were apparently at stage IA, 1 patient at stage IB, and 57 patients at stage IC. The mean age was 47 years old (21-81 years) and the median follow-up period was 110 months (50-179 months). Totally 64 (79.0%) patients received adjuvant chemotherapy. The 5-year overall survival rate was 91.4% and 4-year progression free survival rate was 85.2%, which were similar to the survival rates described in the literature for patients who had undergone systematic lymphadenectomy. Conclusion: With provision of appropriate adjuvant chemotherapy, women with apparent stage I disease who have not undergone pelvic lymphadenectomy may achieve similar long-term survival rate to those who have undergone systematic lymphadectomy.en_US
dc.languageengen_US
dc.publisher上海市腫瘤研究所. The Journal's web site is located at http://zzll.chinajournal.net.cn/en_US
dc.relation.ispartofTumoren_US
dc.subjectLymph Node Excisionen_US
dc.subjectOvarian Neoplasmsen_US
dc.subjectSurvival Rateen_US
dc.titleRetrospective analysis of survival in 81 women with early epithelial ovarian carcinoma who had not undergone systematic lymphadenectomyen_US
dc.typeArticleen_US
dc.identifier.emailChan, KKL:kklchan@hkucc.hku.hken_US
dc.identifier.emailNgan, HYS:hysngan@hkucc.hku.hken_US
dc.identifier.authorityChan, KKL=rp00499en_US
dc.identifier.authorityNgan, HYS=rp00346en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.3781/j.issn.1000-7431.2008.12.010en_US
dc.identifier.scopuseid_2-s2.0-77953450408en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77953450408&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume28en_US
dc.identifier.issue12en_US
dc.identifier.spage1059en_US
dc.identifier.epage1063en_US
dc.publisher.placeChinaen_US
dc.identifier.scopusauthoridChen, JH=36112822400en_US
dc.identifier.scopusauthoridChan, KKL=8655666700en_US
dc.identifier.scopusauthoridTam, KF=7201692816en_US
dc.identifier.scopusauthoridNgan, HYS=34571944100en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats